← Back to headlines
Kerry Group Conference: Biotech Push, Volume-Led Growth, and 19–20% EBITDA Margin Target by 2028
Kerry Group's conference highlighted its biotech initiatives, volume-led growth strategy, and a target of 19–20% EBITDA margin by 2028.
19 Feb, 14:36 — 19 Feb, 14:36
ℹOnly 1 source covers this story
